Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP15 | Q460N3 | 1/20 | 0.46 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.46 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.46 |
| ▸ | FASN | P49327 | 2/20 | 0.44 |
| ▸ | CASP1 | P29466 | 1/20 | 0.44 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.44 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.43 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.43 |
| ▸ | PARP1 | P09874 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | NSD2 | O96028 | 1/20 | 0.40 |
| ▸ | KDR | P35968 | 1/20 | 0.40 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.40 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.40 |
| ▸ | MTOR | P42345 | 1/20 | 0.40 |
| ▸ | GSK3B | P49841 | 1/20 | 0.40 |
| ▸ | PRKDC | P78527 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29360911 | 1.00 | PARP15 (0.46) | PARP15PARP10PARP2FASNCASP1 | |
| SCHEMBL14136790 | 0.85 | CASP1 (0.44) | PARP15PARP10PARP2FASNCASP1 | |
| SCHEMBL3361866 | 0.83 | LRRK2 (0.48) | LRRK2CA1CA2GSK3BMRGPRX4 | |
| SCHEMBL289026 | 0.83 | XDH (0.49) | LRRK2CA1CA2MRGPRX4 | |
| SCHEMBL289547 | 0.81 | LRRK2 (0.44) | LRRK2CA1CA2KDRGSK3B | |
| SCHEMBL5045602 | 0.79 | XDH (0.49) | PARP15PARP10PARP2CASP1MKNK1 | |
| SCHEMBL289565 | 0.79 | LRRK2 (0.45) | CASP1LRRK2CA1CA2ATM | |
| SCHEMBL20787533 | 0.79 | LRRK2 (0.51) | FASNLRRK2KDRALDH1A1 | |
| SCHEMBL30641945 | 0.79 | LRRK2 (0.51) | FASNLRRK2KDRALDH1A1 | |
| SCHEMBL13270694 | 0.79 | LRRK2 (0.42) | LRRK2CA1CA2GSK3BMRGPRX4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240225002-A1 | FUNGICIDAL COMPOSITION CONTAINING OXADIAZOLE COMPOUNDS | PI INDUSTRIES LTD. (IN) | 2024-07-11 | — | — | US | claimed |
| CN-116076518-A | Pyrimidinium compounds and mixtures thereof for combating animal pests | 巴斯夫欧洲公司 | 2023-05-09 | — | — | CN | claimed |
| US-7759390-B2 | chemokine receptor 9(CCR9) antagonists such as, 5-Chloro-thiophene-2-sulfonic acid (4-cyano-2-methyl-phenyl)-amide, used for treating autimmune and inflammatory diseases, transplantat rejection and cancer | NOVARTIS AG (CH) | 2010-07-20 | — | — | US | claimed |
| US-20080300295-A1 | Inhibitors of Ccr9 Activity | NOVARTIS AG (CH) | 2008-12-04 | — | — | US | claimed |
| EP-1966182-A1 | INHIBITORS OF CCR9 ACTIVITY | Novartis AG (CH) | 2008-09-10 | — | — | EP | claimed |
| WO-2007071440-A1 | INHIBITORS OF CCR9 ACTIVITY | NOVARTIS AG (CH) | 2007-06-28 | — | — | WO | claimed |
| EP-4739690-A1 | SUBSTITUTED QUINOLYL/QUINOXALYL DIHYDROPYRROLOTRIAZINE COMPOUNDS FOR COMBATTING PHYTO-PATHOGENIC FUNGI | BASF SE (DE) | 2026-05-13 | — | — | EP | disclosed |
| EP-4739691-A1 | SUBSTITUTED PYRIDYL/PYRAZINYL DIHYDROPYRROLOTRIAZINE COMPOUNDS FOR COMBATTING PHYTOPATH-OGENIC FUNGI | BASF SE (DE) | 2026-05-13 | — | — | EP | disclosed |
| EP-4702006-A1 | USE OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS XVI | BASF SE (DE) | 2026-03-04 | — | — | EP | disclosed |
| EP-4680605-A1 | SUBSTITUTED PYRIDYL/PYRAZIDYL DIHYDROBENZOTHIAZEPINE COMPOUNDS FOR COMBATTING PHYTOPATHOGENIC FUNGI | BASF SE (DE) | 2026-01-21 | — | — | EP | disclosed |
| WO-2025242699-A1 | METHOD FOR IMPROVING RAINFASTNESS OF AN AGROCHEMICAL ACTIVE INGREDIENT | BASF SE (DE) | 2025-11-27 | — | — | WO | disclosed |
| EP-4648851-A1 | SUBSTITUTED (HETERO)ANILINES AND THEIR USE | Astrazeneca AB (SE) | 2025-11-19 | — | — | EP | disclosed |
| EP-4619393-A1 | SUBSTITUTED BENZODIAZEPINES AS FUNGICIDES | BASF SE (DE) | 2025-09-24 | — | — | EP | disclosed |
| US-7759390-B2 | chemokine receptor 9(CCR9) antagonists such as, 5-Chloro-thiophene-2-sulfonic acid (4-cyano-2-methyl-phenyl)-amide, used for treating autimmune and inflammatory diseases, transplantat rejection and cancer | NOVARTIS AG (CH) | 2010-07-20 | — | — | US | disclosed |
| US-20100010093-A1 | ANTIPARASITIC AGENTS | PFIZER LIMITED (GB) | 2010-01-14 | — | — | US | disclosed |
| US-7608604-B2 | Antiparasitic agents | PFIZER LIMITED (GB) | 2009-10-27 | — | — | US | disclosed |
| US-20080300295-A1 | Inhibitors of Ccr9 Activity | NOVARTIS AG (CH) | 2008-12-04 | — | — | US | disclosed |
| EP-1966182-A1 | INHIBITORS OF CCR9 ACTIVITY | Novartis AG (CH) | 2008-09-10 | — | — | EP | disclosed |
| US-20080194694-A1 | nematocides such as N-{1-cyano-2-[5-cyano-2-(trifluoromethyl)phenoxy]-1-methylethyl}-4-pentafluorothiobenzamide, tautomers or prodrugs, carriers and optionally a second therapeutic agent, used for treating parasitic infestations | PFIZER LIMITED (UK) | 2008-08-14 | — | — | US | disclosed |
| WO-2007071440-A1 | INHIBITORS OF CCR9 ACTIVITY | NOVARTIS AG (CH) | 2007-06-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080194694-A1 | nematocides such as N-{1-cyano-2-[5-cyano-2-(trifluoromethyl)phenoxy]-1-methylethyl}-4-pentafluorothiobenzamide, tautomers or prodrugs, carriers and optionally a second therapeutic agent, used for treating parasitic infestations | HRH4, HRH3, HRH2 | PARP15 4051/4885PARP10 4716/4885PARP2 3717/4885 |
| US-20080300295-A1 | Inhibitors of Ccr9 Activity | CCR9, CCR1, CCR4 | PARP15 1774/4885PARP10 2399/4885PARP2 2679/4885 |
| US-20100010093-A1 | ANTIPARASITIC AGENTS | HRH3, CYTH3, HRH4 | PARP15 1430/4885PARP10 2215/4885PARP2 1324/4885 |
| US-20240225002-A1 | FUNGICIDAL COMPOSITION CONTAINING OXADIAZOLE COMPOUNDS | OXA1L, NOX1, NOX3 | PARP15 4779/4885PARP10 4849/4885PARP2 4871/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.